summary
Introduced
03/17/2025
03/17/2025
In Committee
03/17/2025
03/17/2025
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for definitions.
AI Summary
This bill amends the definition of "drug" in the Controlled Substance, Drug, Device and Cosmetic Act by adding a specific definition for "vaccine or vaccine material". The updated definition describes a vaccine as a substance intended to be used in humans to stimulate antibody production and provide disease immunity, prepared from a disease's causative agent, its products, or a synthetic substitute, which has been treated to act as an antigen without causing the disease. The bill specifically adds that such a vaccine must be authorized or approved by the United States Food and Drug Administration (FDA). This clarification helps provide a more precise legal definition of vaccines, which could have implications for how vaccines are regulated, manufactured, distributed, and classified under Pennsylvania state law. The amendment appears to be a technical update to ensure legal terminology around vaccines is clear and aligned with current medical understanding and federal regulatory standards.
Committee Categories
Health and Social Services
Sponsors (5)
Last Action
Referred to Health & Human Services (on 03/17/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...